13F-HR filed by Octagon Capital Advisors LP
Octagon Capital Advisors LP filed this 13F-HR for the quarter ended 2024-06-30, filed 2024-08-14, with 46 holding rows worth $636,276,129.
- Accession
- 0001839435-24-000005
- Filer
- CIK 1839435
- Filed
- 2024-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2024
A holdings report, 47 entries on the cover page, a total value of $636,276,129 stated on the cover page (in dollars after the unit check, H1), rows summing to $636,276,129 with VALUE read as dollars as filed, 13F file number 028-20958. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 2,880,880 | $110,510,557 | dollars as filed | |
| DIANTHUS THERAPEUTICS INC | 252828108 | COM | 1,746,667 | $45,203,742 | dollars as filed | |
| STRUCTURE THERAPEUTICS INC COMP | 86366E106 | EQUITY | 1,140,060 | $44,770,156 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 650,216 | $43,564,472 | dollars as filed | |
| DYNE THERAPEUTICS INC COM | 26818M108 | Stock | 1,180,798 | $41,670,361 | dollars as filed | |
| ARRIVENT BIOPHARMA INC | 04272N102 | COM | 1,803,304 | $33,451,289 | dollars as filed | |
| VERONA PHARMA PLC | 925050106 | SPONSORED ADS | 1,895,200 | $27,404,592 | dollars as filed | |
| CORBUS PHARMACEUTICALS | 21833P301 | COM NEW | 488,000 | $22,082,000 | dollars as filed | |
| CENTESSA PHARMACEUTICALS PLC | 152309100 | SPONSORED ADS | 2,345,075 | $21,176,027 | dollars as filed | |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 690,000 | $17,477,700 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 250,000 | $16,750,000 | dollars as filed | call |
| OCULAR THERAPEUTIX INC | 67576A100 | COM | 2,425,000 | $16,587,000 | dollars as filed | |
| PERSPECTIVE THERAPEUTICS INC | 46489V302 | COMMON STOCK | 1,580,249 | $15,755,083 | dollars as filed | |
| MIND MEDICINE MINDMED INC | 60255C885 | COM NEW | 2,153,000 | $15,523,130 | dollars as filed | |
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 350,000 | $13,426,000 | dollars as filed | call |
| PRAXIS PRECISION MEDICINES I | 74006W207 | COM NEW | 260,000 | $10,753,600 | dollars as filed | |
| TAYSHA GENE THERAPIES INC | 877619106 | COMMON STOCK | 4,572,222 | $10,241,777 | dollars as filed | |
| EYEPOINT INC COM NEW | 30233G209 | Stock | 1,093,503 | $9,513,476 | dollars as filed | |
| TERNS PHARMACEUTICALS INC COM | 880881107 | Stock | 1,364,400 | $9,291,564 | dollars as filed | |
| GOSSAMER BIO INC COM | 38341P102 | Stock | 9,187,883 | $8,277,364 | dollars as filed | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 620,000 | $8,066,200 | dollars as filed | |
| TENAYA THERAPEUTICS INC | 87990A106 | COM | 2,576,200 | $7,986,220 | dollars as filed | |
| REGULUS THERAPEUTICS INC | 75915K309 | COM | 4,263,701 | $7,610,706 | dollars as filed | |
| ALLOVIR INC | 019818103 | COM | 9,800,000 | $7,088,340 | dollars as filed | |
| MINERALYS THERAPEUTICS INC | 603170101 | COM | 600,000 | $7,020,000 | dollars as filed | |
| AN2 THERAPEUTICS INC | 037326105 | COM | 3,220,263 | $6,923,565 | dollars as filed | |
| AKERO THERAPEUTICS INC | 00973Y108 | COM | 283,372 | $6,647,907 | dollars as filed | |
| JASPER THERAPEUTICS INC | 471871202 | COM NEW | 287,500 | $6,526,250 | dollars as filed | |
| PEPGEN INC COM | 713317105 | Stock | 376,117 | $6,002,827 | dollars as filed | |
| Ventyx Biosciences Inc | 92332V107 | Common Stock | 2,391,114 | $5,523,473 | dollars as filed | |
| CYBIN INC | 23256X100 | COM | 18,604,650 | $5,041,860 | dollars as filed | |
| CENTURY THERAPEUTICS INC | 15673T100 | COM | 1,333,650 | $3,400,808 | dollars as filed | |
| RENEO PHARMACEUTICALS INC | 75974E103 | COM | 2,250,000 | $3,397,500 | dollars as filed | |
| SILENCE THERAPEUTICS PLC | 82686Q101 | ADS | 176,000 | $3,344,000 | dollars as filed | |
| HELIX ACQUISITION CORP II | G4444H101 | CL A ORD SHS | 250,000 | $2,555,000 | dollars as filed | |
| POSEIDA THERAPEUTICS INC | 73730P108 | COM | 736,000 | $2,149,120 | dollars as filed | |
| ELEVATION ONCOLOGY INC COM | 28623U101 | Stock | 747,000 | $2,016,900 | dollars as filed | |
| Mersana Therapeutics Inc | 59045L106 | Common Stock | 992,000 | $1,993,920 | dollars as filed | |
| ANNEXON INC | 03589W102 | COM | 400,000 | $1,960,000 | dollars as filed | |
| FATE THERAPEUTICS INC | 31189P102 | COM | 520,800 | $1,708,224 | dollars as filed | |
| NKARTA INC | 65487U108 | COMMON STOCK | 240,000 | $1,418,400 | dollars as filed | |
| NUVATION BIO INC COM CL A | 67080N101 | Stock | 431,600 | $1,260,272 | dollars as filed | |
| ADICET BIO INC | 007002108 | COM | 767,799 | $929,037 | dollars as filed | |
| RAPT THERAPEUTICS INC | 75382E109 | COM | 292,000 | $890,600 | dollars as filed | |
| AEROVATE THERAPEUTICS INC | 008064107 | COM | 465,440 | $772,630 | dollars as filed | |
| AUTOLUS THERAPEUTICS PLC SPON | 05280R100 | COM | 176,000 | $612,480 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001839435-24-000005 | this filing | 2024-08-14 | acceptance time not in the bulk data set |